January 29, 2018
Actavis Laboratories FL Inc. will be able to launch its generic version of the hydrocodone-based painkiller Zohydro ER in March 2029, Pernix Therapeutics Holdings Inc. announced Monday as part of a settlement ending patent infringement litigation in Delaware federal court.